Comparison of enzymatic and anatomic estimates of myocardial infarct size in man

D. B. Hackel, K. A. Reimer, R. E. Ideker, E. M. Mikat, T. D. Hartwell, C. B. Parker, E. B. Braunwald, M. Buja, H. K. Gold, Allan S Jaffe

Research output: Contribution to journalArticle

113 Citations (Scopus)

Abstract

Enzymatic estimates of myocardial infarct size based on plasma levels of MB creatine kinase (MB-CK) were compared with anatomic infarct size in 49 human hearts obtained at autopsy. The patients studied had been enrolled in the Multicenter Investigation of Limitation of Infarct Size (MILIS) study program within 18 hr of the onset of acute infarction and were treated at one of five participating hospitals. Infarct size was estimated from serial measurements of plasma MB-CK made at the core laboratory for CK analysis. Hearts obtained at autopsy were studied independently by the core pathology laboratory without knowledge of the MB-CK levels or clinical results. Data from the two laboratories were compared at the data coordinating center. Of 49 hearts, 12 were excluded either because anatomic infarct size could not be established or because the infarct occurring at the time of enrollment in the MILIS study could not be distinguished with certainty from other infarcts. Of the remaining 37 hearts, peak MB-CK level was available in 36, but samples sufficient for estimation of infarct size were available in only 25. The overall correlation coefficient (Spearman) was .87 for these 25 hearts, indicating that enzymatic estimates of infarct size correlate closely with anatomic measurements. The results indicate that CK estimates of myocardial infarct size represent a valid clinical end point for assessing myocardial infarct size, and the effect of therapy thereon, in groups of treated and control patients.

Original languageEnglish (US)
Pages (from-to)824-835
Number of pages12
JournalCirculation
Volume70
Issue number5
StatePublished - 1984
Externally publishedYes

Fingerprint

MB Form Creatine Kinase
Myocardial Infarction
Autopsy
Infarction
Pathology
Control Groups
Therapeutics

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Hackel, D. B., Reimer, K. A., Ideker, R. E., Mikat, E. M., Hartwell, T. D., Parker, C. B., ... Jaffe, A. S. (1984). Comparison of enzymatic and anatomic estimates of myocardial infarct size in man. Circulation, 70(5), 824-835.

Comparison of enzymatic and anatomic estimates of myocardial infarct size in man. / Hackel, D. B.; Reimer, K. A.; Ideker, R. E.; Mikat, E. M.; Hartwell, T. D.; Parker, C. B.; Braunwald, E. B.; Buja, M.; Gold, H. K.; Jaffe, Allan S.

In: Circulation, Vol. 70, No. 5, 1984, p. 824-835.

Research output: Contribution to journalArticle

Hackel, DB, Reimer, KA, Ideker, RE, Mikat, EM, Hartwell, TD, Parker, CB, Braunwald, EB, Buja, M, Gold, HK & Jaffe, AS 1984, 'Comparison of enzymatic and anatomic estimates of myocardial infarct size in man', Circulation, vol. 70, no. 5, pp. 824-835.
Hackel DB, Reimer KA, Ideker RE, Mikat EM, Hartwell TD, Parker CB et al. Comparison of enzymatic and anatomic estimates of myocardial infarct size in man. Circulation. 1984;70(5):824-835.
Hackel, D. B. ; Reimer, K. A. ; Ideker, R. E. ; Mikat, E. M. ; Hartwell, T. D. ; Parker, C. B. ; Braunwald, E. B. ; Buja, M. ; Gold, H. K. ; Jaffe, Allan S. / Comparison of enzymatic and anatomic estimates of myocardial infarct size in man. In: Circulation. 1984 ; Vol. 70, No. 5. pp. 824-835.
@article{235ec605a67b40c49637ed02b5d87437,
title = "Comparison of enzymatic and anatomic estimates of myocardial infarct size in man",
abstract = "Enzymatic estimates of myocardial infarct size based on plasma levels of MB creatine kinase (MB-CK) were compared with anatomic infarct size in 49 human hearts obtained at autopsy. The patients studied had been enrolled in the Multicenter Investigation of Limitation of Infarct Size (MILIS) study program within 18 hr of the onset of acute infarction and were treated at one of five participating hospitals. Infarct size was estimated from serial measurements of plasma MB-CK made at the core laboratory for CK analysis. Hearts obtained at autopsy were studied independently by the core pathology laboratory without knowledge of the MB-CK levels or clinical results. Data from the two laboratories were compared at the data coordinating center. Of 49 hearts, 12 were excluded either because anatomic infarct size could not be established or because the infarct occurring at the time of enrollment in the MILIS study could not be distinguished with certainty from other infarcts. Of the remaining 37 hearts, peak MB-CK level was available in 36, but samples sufficient for estimation of infarct size were available in only 25. The overall correlation coefficient (Spearman) was .87 for these 25 hearts, indicating that enzymatic estimates of infarct size correlate closely with anatomic measurements. The results indicate that CK estimates of myocardial infarct size represent a valid clinical end point for assessing myocardial infarct size, and the effect of therapy thereon, in groups of treated and control patients.",
author = "Hackel, {D. B.} and Reimer, {K. A.} and Ideker, {R. E.} and Mikat, {E. M.} and Hartwell, {T. D.} and Parker, {C. B.} and Braunwald, {E. B.} and M. Buja and Gold, {H. K.} and Jaffe, {Allan S}",
year = "1984",
language = "English (US)",
volume = "70",
pages = "824--835",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Comparison of enzymatic and anatomic estimates of myocardial infarct size in man

AU - Hackel, D. B.

AU - Reimer, K. A.

AU - Ideker, R. E.

AU - Mikat, E. M.

AU - Hartwell, T. D.

AU - Parker, C. B.

AU - Braunwald, E. B.

AU - Buja, M.

AU - Gold, H. K.

AU - Jaffe, Allan S

PY - 1984

Y1 - 1984

N2 - Enzymatic estimates of myocardial infarct size based on plasma levels of MB creatine kinase (MB-CK) were compared with anatomic infarct size in 49 human hearts obtained at autopsy. The patients studied had been enrolled in the Multicenter Investigation of Limitation of Infarct Size (MILIS) study program within 18 hr of the onset of acute infarction and were treated at one of five participating hospitals. Infarct size was estimated from serial measurements of plasma MB-CK made at the core laboratory for CK analysis. Hearts obtained at autopsy were studied independently by the core pathology laboratory without knowledge of the MB-CK levels or clinical results. Data from the two laboratories were compared at the data coordinating center. Of 49 hearts, 12 were excluded either because anatomic infarct size could not be established or because the infarct occurring at the time of enrollment in the MILIS study could not be distinguished with certainty from other infarcts. Of the remaining 37 hearts, peak MB-CK level was available in 36, but samples sufficient for estimation of infarct size were available in only 25. The overall correlation coefficient (Spearman) was .87 for these 25 hearts, indicating that enzymatic estimates of infarct size correlate closely with anatomic measurements. The results indicate that CK estimates of myocardial infarct size represent a valid clinical end point for assessing myocardial infarct size, and the effect of therapy thereon, in groups of treated and control patients.

AB - Enzymatic estimates of myocardial infarct size based on plasma levels of MB creatine kinase (MB-CK) were compared with anatomic infarct size in 49 human hearts obtained at autopsy. The patients studied had been enrolled in the Multicenter Investigation of Limitation of Infarct Size (MILIS) study program within 18 hr of the onset of acute infarction and were treated at one of five participating hospitals. Infarct size was estimated from serial measurements of plasma MB-CK made at the core laboratory for CK analysis. Hearts obtained at autopsy were studied independently by the core pathology laboratory without knowledge of the MB-CK levels or clinical results. Data from the two laboratories were compared at the data coordinating center. Of 49 hearts, 12 were excluded either because anatomic infarct size could not be established or because the infarct occurring at the time of enrollment in the MILIS study could not be distinguished with certainty from other infarcts. Of the remaining 37 hearts, peak MB-CK level was available in 36, but samples sufficient for estimation of infarct size were available in only 25. The overall correlation coefficient (Spearman) was .87 for these 25 hearts, indicating that enzymatic estimates of infarct size correlate closely with anatomic measurements. The results indicate that CK estimates of myocardial infarct size represent a valid clinical end point for assessing myocardial infarct size, and the effect of therapy thereon, in groups of treated and control patients.

UR - http://www.scopus.com/inward/record.url?scp=0021687697&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021687697&partnerID=8YFLogxK

M3 - Article

C2 - 6488496

AN - SCOPUS:0021687697

VL - 70

SP - 824

EP - 835

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 5

ER -